Magnesium sulfate therapy in certain emergency conditions

American Journal of Emergency Medicine

Volumn 15, Issue 2, 1997, Pages 182-187

  Frakes, Michael A ^a   Richardson II, Lester E ^b  

^a Douglas County Division of EMS   (United States)

^b Shawnee Mission Medical Center   (United States)

Author keywords

arrhythmia; asthma; eclampsia; Magnesium; myocardial infarction; preeclampsia

Indexed keywords

MAGNESIUM SULFATE;

ARTICLE; ASTHMA; DRUG EFFICACY; ECLAMPSIA; EMERGENCY TREATMENT; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; PREECLAMPSIA; PRIORITY JOURNAL;

EID: 0030944176     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(97)90098-X     Document Type: Article

References (81)

1. McLean R: Magnesium and its therapeutic uses: A review. Am J Med 1994;96:63-76
2. Tso EL, Barish RA: Magnesium: Clinical considerations. J Emerg Med 1992;10:743-745
3. Wacker WEC, Parisi AF: Magnesium metabolism. N Engl J Med 1968;278:658-663, 712-717, 772-776
4. Reinhart RA: Magnesium metabolism. Arch Intern Med 1988; 148:2415-2420
5. Elin RJ: Magnesium metabolism in health and disease. Dis Month 1988;34:161-178
6. Repke JT, Friedman SA, Kaplan PW: Prophylaxis of eclamptic seizures: Current controversies. Clin Obstet Gynecol 1992;35:365-374
7. Sibai BM: Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol 1990;162:1141-1145
8. Haury VG: Blood serum magnesium in bronchial asthma and its treatment by the administration of magnesium sulfate. J Lab Clin Med 1940;25:340-344
9. Okayama H, Aikawa T, Okayama M, et al: Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma. JAMA 1987; 257:1076-1078
10. Skobeloff EM, Spivey WH, McNamara RM, Greenspoon L: Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA 1989;262:1201-1213
11. Noppen M, Vanmaele L, Impens N, Schandevyll W: Bronchodilating effect of intravenous magnesium sulfate in acute severe bronchial asthma. Chest 1990;97:373-376
12. Green SM, Rothrock SG: Intravenous magnesium for acute asthma: Failure to decrease emergency treatment duration or need for hospitalization. Ann Emerg Med 1992;21:260-265
13. Tiffany BR, Berk WA, Todd IK, White SR: Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations. Chest 1993;104:831-834
14. Bloch H, Silverman R, Mancherje N, et al: Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma. Chest 1994;107:1576-1581
15. Schiermeyer RP, Finkelstein JA: Rapid infusion of magnesium sulfate obviates need for intubation in status asthmaticus. Am J Emerg Med 1994;12:164-166
16. McNamara RM, Spivey WH, Skobeloff E, Jacubowitz S: Intravenous magnesium sulfate in the management of acute respiratory failure complicating asthma. Ann Emerg Med 1989;18:197-9.
17. Pabon H, Monem G, Kissoon N: Safety and efficacy of magnesium sulfate infusions in children with status asthmaticus. Pediatr Emerg Care 1994;10:200-203
18. Skorodin MS, Freebeck PC, Yetter B, et al: Magnesium sulfate potentiates several cardiovascular and metabolic actions of terbutaline. Chest 1994;105:701-705
19. Pritchard JA, Cunningham FG, Pritchard SA: The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases. Am J Obstet Gynecol 1984;148:951-963
20. Falkner D, Glauser J, Allen M: Serum magnesium levels in asthmatic patients during acute exacerbations of asthma. Am J Emerg Med 1992;10:1-3
21. Rolla G, Bucca C, Carie E, et al: Acute effect of intravenous magnesium sulfate on airway obstruction of asthmatic patients. Ann Allergy 1988;61:388-391
22. Fesmire F: Intravenous magnesium for acute asthma. Ann Emerg Med 1993;22:616-617 (comment)
23. Wright JW, Ridgway LE, Patterson RM: Adjusting the loading dose of magnesium sulfate for tocolysis. Am J Obstet Gynecol 1990;162:889-892
24. Skobeloff EM, McNamara RM: Intravenous magnesium for acute asthma. Ann Emerg Med 1993;22:618 (comment)
25. McCombs J: Treatment of preeclampsia and eclampsia. Clin Pharm 1992;11:236-245
26. Zuspan FP, Zuspan KJ: Acute and chronic hypertension during pregnancy. In Rayburn WF, Zuspan FP (eds): Drug Therapy in Obstetrics and Gynecology. East Norwalk, CT, Appleton-Century-Crofts, 1986, pp 73-92
27. Sibai BM, Lipshitz J, Anderson GD, et al: Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia. Obstet Gynecol 1981;57:199-202
28. Management of preeclampsia. Am Coll Obstet Gynecol Tech Bull February 1986;91:1-4
29. Pritchard JA: The use of the magnesium ion in the management of eclampogenic toxemias. Surg Gynecol Obstet 1955;100:131-140
30. Zuspan FP: Treatment of severe preeclampsia and eclampsia. Clin Obstet Gynecol 1966;9:954-972
31. Sibai BM, Graham JM, McCubbin JH: A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol 1984;150:728-733
32. Repke JT, Friedman SA, Kaplan PW: Prophylaxis of eclamptic seizures: Current controversies. Clin Obstet Gynecol 1992;35:365-374
33. Kaplan PW, Lesser RP, Fisher RS, et al: A continuing controversy: Magnesium sulfate in the treatment of eclamptic seizures. Arch Neurol 1990;47:1031-1032
34. Kaplan PW, Lesser RP, Fisher RS, et al: No, magnesium sulfate should not be used in treating eclamptic seizures. Arch Neurol 1988;45:1361-1364
35. Zuspan FP: Problems encountered in the treatment of pregnancy-induced hypertension. Am J Obstet Gynecol 1978;131:591-596
36. Lucas MJ: A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995;333:210-215
37. Domisse J: Phenytoin sodium and magnesium sulfate in the management of eclampsia. Br J Obstet Gynaecol 1990;94:104
38. Crowther C: Magnesium sulfate versus diazepam in the management of eclampsia: A randomized clinical trial. Br J Obstet Gynaecol 1990;97:110-117
39. Sibai BM: Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol 1990;162:1141-1145
40. Goodlin RC: Magnesium sulfate is not an ideal anticonvulsant. Am J Obstet Gynecol 1990;163:1714-1715
41. Hachinski V: Magnesium sulfate in the treatment of eclampsia. Arch Neurol 1989;46:947-948 (comment and reply)
42. Tzivoni D, Banai S, Schuger C, et al: Treatment of torsade de pointes with magnesium sulfate. Circulation 1988;77:392-397
43. Tzivoni D, Keren A, Cohen A, et al: Magnesium therapy for torsades de pointes. Am J Cardiol 1984;53:528-530
44. Perticone F, Adinolfi L, Bonaduce D: Efficacy of magnesium sulfate in the treatment of torsade de pointes. Am Heart J 1986;112: 847-849
45. Cummins RO (ed): Textbook of Advanced Cardiac Life Support. Dallas, TX, American Heart Association, 1994, pp 1-17, 1-39
46. Allen BJ, Brodsky MA, Capparelli EV, et al: Magnesium sulfate therapy for sustained monomorphic ventricular tachycardia. Am J Cardiol 1989;64:1202-1204
47. Tsuji H, Venditti FJ, Evans JC, et al: The associations of levels of serum potassium and magnesium with ventricular premature compleses. Am J Cardiol 1994;74:232-235
48. Teo KK, Yusuf S: Role of magnesium in reducing mortality in acute myocardial infarction. Drugs 1993;46:347-359
49. DeCarli C, Sprouse G, LaRosa JC: Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin. Am J Cardiol 1986;57:956-959
50. Brodsky MA, Orlov MV, Capparelli EV, et al: Magnesium therapy in new-onset atrial fibrillation. Am J Cardiol 1994;73:1227-1229
51. Kimura T, Yasue H, Sakaino N, et al: Effects of magnesium on the tone of isolated human coronary arteries. Circulation 1989;79: 1118-1124
52. Kugiyama K, Yasua H, Okumura K, et al: Suppression of exercised induced angina by magnesium sulfate in patients with variant angina. J Am Coll Cardiol 1988;12:1177-1183
53. Vigorito C, Giordano A, Ferraro P, et al: Hemodynamic effects of magnesium sulfate on the normal human heart. Am J Cardiol 1991;67:1435-1437
54. Mroczek WJ, Lee WR, Davidov ME: Effect of magnesium sulfate on cardiovascular hemodynamics. Angiology 1977;28:720-724
55. Adams JH, Mitchell JRA: The effect of agents which modify platelet behavior and of magnesium ions on thrombus formation in vivo. Thrombosis Haemostasis. 1979;42:603-610
56. Watson KV, Moldow CF, Ogburn PL, et al: Magnesium sulfate: Rationale for its use in pre-eclampsia. Proc Natl Acad Sci USA 1986;83:1075-1078
57. Tzivoni D, Keren A: Suppression of ventricular arrhythmias by magnesium. Am J Cardiol 1990;65:1387-1399
58. Iseri LR, Fairshter RD, Hardemann JL, Brodsky MA: Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J 1985;110:789-794
59. Haverkamp W, Hindricks G, Keteller T, et al: Prophylactic antiarrhythmic and antifibrillatory effects of intravenous magnesium sulfate during acute myocardial ischemia. Eur Heart J 1988;9:228
60. Chang C, Varghese PJ, Downey J, Bloom S: Magnesium deficiency and myocardial infarct size in the dog. J Am Coll Cardiol 1985;5:280-289
61. Bolli R, Jeroudi MO, Patel BS, et al: Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res 1989;65:607-622
62. Bolli R: Mechanism of myocardial "stunning." Circulation 1990;83:723-738
63. de Wood MA, Spores J, Notske R, et al: Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902
64. Ferrari R, Albertini A, Curello S, et al: Myocardial recovery during post-ischemic reperfusion: Effects of nifedipene, calcium and magnesium. J Mol Cell Cardiol 1986;18:487-498
65. Hearse DJ, Stewart DA, Braimbridge MHV: Myocardial protection during ischemic cardiac arrest. J Thorac Cardiovasc Surg 1978;75:877-895
66. du Toit EF, Opie LH: Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res 1992;70:960-967
67. Ceremuzynski L, Jurigel R, Kulakoswski P, Gebalska J: Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate. Am Heart J 1989;118:1333-1334
68. Feldstedt M, Bosegaaard S, Bouchelouche P, et al: Magnesium substitution in acute ischemic heart syndromes. Eur Heart J 1991;12:1215-1218
69. Morton BC, Nari RC, Smith FM, et al: Magnesium therapy in acute myocardial infarction - A double-blind study. Magnesium 1984; 3:346-352
70. Rasmussen HS, Gronbaek M, Cintin C, et al: One year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo. Clin Cardiol 1988;11:377-381
71. Shechter M, Hod H, Marks N, et al: Magnesium therapy and mortality in acute myocardial infarction. Am J Cardiol 1990;66:271-274
72. Shechter M, Hod H: Magnesium therapy in aged patients with acute myocardial infarction. Magnesium Bulletin 1991;13:7-9
73. Shechter M, Hod H, Kaplinsky E, Rabinowitz B: Magnesium administration in patients with acute myocardial infarction who are not candidates for thrombolytic therapy. Eur Heart J 1991;12:401
74. Singh RB, Sircar AR, Rastogi SS, Garg V: Magnesium and potassium administration in acute myocardial infarction. Magnesium Trace Elements 1990;9:198-204
75. Smith LF, Heagerty AM, Bing RF, Barnett DB: Intravenous infusion of magnesium sulfate after myocardial infarction: Effects on arrhythmias and mortality. Intl J Cardiol 1986;12:175-180
76. Woods KL, Fletcher S, Roffe C, Haider Y: Intravenous magnesium sulfate in suspected acute myocardial infarction: Results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992;339:1553-1558
77. Woods KL, Fletcher S: Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: The second Leicester Intravenous Magnesium Trial (LIMIT-2). Lancet 1994;343:816-819
78. Hampton EM, Whang DD, Whang R: Intravenous magnesium therapy in acute myocardial infarction. Ann Pharmacother 1994;28: 212-219
79. Fourth International Study of Infarct Survival Collaborative Group. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685
80. Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major mortality results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-322
81. Casscells W: Magnesium and myocardial infarction. Lancet 1994;343:807-809